Quarterly report pursuant to Section 13 or 15(d)

Condensed Balance Sheets

v3.19.3
Condensed Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2019
Dec. 31, 2018
Current assets:    
Cash and cash equivalents $ 71,041 $ 33,017
Prepaid expenses and other current assets 708 977
Total current assets 71,749 33,994
Property and equipment, net 540  
Deferred offering costs 2,563 180
Deposits 91  
Total Assets 74,943 34,174
Current liabilities:    
Accounts payable 1,154 603
Accrued and other current liabilities 1,910 340
Total current liabilities 3,064 943
Commitments and Contingencies (see Note 6)
Convertible preferred stock:    
Series A, A-1, A-2 and B convertible preferred stock, $0.00001 par value: 20,762,168 and 12,393,497 shares authorized as of September 30, 2019 and December 31, 2018, respectively; 19,356,835 and 12,393,047 shares issued and outstanding at September 30, 2019 and December 31, 2018, respectively; aggregate liquidation preference of $94,475 at September 30, 2019. 97,954 43,921
Stockholders’ deficit:    
Common stock, $0.00001 par value: 29,000,000 and 21,147,115 shares authorized as of September 30, 2019 and December 31, 2018, respectively; 3,848,320 shares issued and outstanding at both December 31, 2018 and September 30, 2019 0 0
Additional paid-in capital 1,481 1,762
Accumulated deficit (27,556) (12,452)
Total stockholders’ deficit (26,075) (10,690)
Total liabilities, convertible preferred stock and stockholders’ deficit $ 74,943 $ 34,174